{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:49:47Z","timestamp":1777463387480,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST106-2313-B-005 -059 - and MOST107-2311-B-005 -011 -MY3"],"award-info":[{"award-number":["MOST106-2313-B-005 -059 - and MOST107-2311-B-005 -011 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12917-019-1883-z","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T16:04:49Z","timestamp":1558109089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Significance of sphingosine kinase 1 expression in feline mammary tumors"],"prefix":"10.1186","volume":"15","author":[{"given":"Yi-Chih","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Li","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn-Wang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ter-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0144-1388","authenticated-orcid":false,"given":"Yu-Chih","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"issue":"2","key":"1883_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0300985814543198","volume":"52","author":"SW Mills","year":"2015","unstructured":"Mills SW, Musil KM, Davies JL, Hendrick S, Duncan C, Jackson ML, et al. Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis. Vet Pathol. 2015;52(2):238\u201349.","journal-title":"Vet Pathol"},{"issue":"3","key":"1883_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jfms.2010.01.004","volume":"12","author":"F Gim\u00e9nez","year":"2010","unstructured":"Gim\u00e9nez F, Hecht S, Craig LE, Legendre AM. Early detection, aggressive therapy: optimizing the management of feline mammary masses. J Feline Med Surg. 2010;12(3):214\u201324.","journal-title":"J Feline Med Surg"},{"key":"1883_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/B978-072160558-6.50029-0","volume-title":"Withrow and Macewan\u2019s small animal clinical oncology","author":"S Lana","year":"2007","unstructured":"Lana S, Rutteman GR, Withrow SJ. Tumors of the mammary gland. In: Withrow SJ, Vail DM, editors. Withrow and Macewan\u2019s small animal clinical oncology. 4th ed. Philadelphia, PA: Saunders Elsevier; 2007. p. 619\u201336.","edition":"4"},{"issue":"1","key":"1883_CR4","first-page":"33","volume":"43","author":"JR Viste","year":"2002","unstructured":"Viste JR, Myers SL, Singh B, Simko E. Feline mammary adenocarcinoma: tumor size as a prognostic indicator. Can Vet J. 2002;43(1):33\u20137.","journal-title":"Can Vet J"},{"issue":"1","key":"1883_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tvjl.2009.10.030","volume":"187","author":"F Seixas","year":"2011","unstructured":"Seixas F, Palmeira C, Pires MA, Bento MJ, Lopes C. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis. Vet J. 2011;187(1):65\u201371.","journal-title":"Vet J"},{"issue":"1","key":"1883_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/0300985814528221","volume":"52","author":"V Zappulli","year":"2015","unstructured":"Zappulli V, Rasotto R, Caliari D, Mainenti M, Pe\u00f1a L, Goldschmidt MH, et al. Prognostic evaluation of feline mammary carcinomas: a review of the literature. Vet Pathol. 2015;52(1):46\u201360.","journal-title":"Vet Pathol"},{"issue":"1","key":"1883_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tvjl.2010.12.016","volume":"191","author":"L Maniscalco","year":"2012","unstructured":"Maniscalco L, Iussich S, de Las Mulas JM, Mill\u00e1n Y, Biolatti B, Sasaki N, et al. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours. Vet J. 2012;191(1):65\u201371.","journal-title":"Vet J"},{"issue":"3","key":"1883_CR8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/0008-5472.907.65.3","volume":"65","author":"R De Maria","year":"2005","unstructured":"De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B, et al. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res. 2005;65(3):907\u201312.","journal-title":"Cancer Res"},{"key":"1883_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2407-10-156","volume":"10","author":"GP Burrai","year":"2010","unstructured":"Burrai GP, Mohammed SI, Miller MA, Marras V, Pirino S, Addis MF, et al. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions. BMC Cancer. 2010;10:156.","journal-title":"BMC Cancer"},{"issue":"4","key":"1883_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1476-5829.2009.00194.x","volume":"7","author":"JF Borrego","year":"2009","unstructured":"Borrego JF, Cartagena JC, Engel J. Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002-2007). Vet Comp Oncol. 2009;7(4):213\u201321.","journal-title":"Vet Comp Oncol"},{"issue":"3","key":"1883_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1354\/vp.08-VP-0161-D-FL","volume":"46","author":"K Sayasith","year":"2009","unstructured":"Sayasith K, Sirois J, Dor\u00e9 M. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas. Vet Pathol. 2009;46(3):423\u20139.","journal-title":"Vet Pathol"},{"issue":"6","key":"1883_CR12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1354\/vp.44-6-842","volume":"44","author":"F Seixas","year":"2007","unstructured":"Seixas F, Palmeira C, Pires MA, Lopes C. Mammary invasive micropapillary carcinoma in cats: clinicopathologic features and nuclear DNA content. Vet Pathol. 2007;44(6):842\u20138.","journal-title":"Vet Pathol"},{"issue":"2","key":"1883_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/104063870301500205","volume":"15","author":"G Sarli","year":"2003","unstructured":"Sarli G, Preziosi R, Benazzi C, Bazzo R, Mandrioli L, Marcato PS. Rate of apoptosis in feline mammary tumors is not predictive of postsurgical survival. J Vet Diagn Investig. 2003;15(2):115\u201322.","journal-title":"J Vet Diagn Investig"},{"issue":"2","key":"1883_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.tvjl.2007.01.006","volume":"175","author":"JS Morris","year":"2008","unstructured":"Morris JS, Nixon C, Bruck A, Nasir L, Morgan IM, Philbey AW. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53. Vet J. 2008;175(2):218\u201326.","journal-title":"Vet J"},{"issue":"7","key":"1883_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1292\/jvms.62.743","volume":"62","author":"Y Murakami","year":"2000","unstructured":"Murakami Y, Tateyama S, Rungsipipat A, Uchida K, Yamaguchi R. Immunohistochemical analysis of cyclin a, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. J Vet Med Sci. 2000;62(7):743\u201350.","journal-title":"J Vet Med Sci"},{"issue":"20","key":"1883_CR16","doi-asserted-by":"crossref","first-page":"29563","DOI":"10.18632\/oncotarget.9007","volume":"7","author":"YC Wang","year":"2016","unstructured":"Wang YC, Tsai CF, Chuang HL, Chang YC, Chen HS, Lee JN, et al. Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1\/S1P\/S1PR3 signaling. Oncotarget. 2016;7(20):29563\u201376.","journal-title":"Oncotarget."},{"issue":"3","key":"1883_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1158\/0008-5472.CAN-11-2167","volume":"72","author":"M Nagahashi","year":"2012","unstructured":"Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res. 2012;72(3):726\u201335.","journal-title":"Cancer Res"},{"issue":"7","key":"1883_CR18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/0008-5472.CAN-17-1423","volume":"78","author":"M Nagahashi","year":"2018","unstructured":"Nagahashi M, Yamada A, Katsuta E, Aoyagi T, Huang WC, Terracina KP, et al. Targeting the SphK1\/S1P\/S1PR1 Axis that links obesity, chronic inflammation, and breast Cancer metastasis. Cancer Res. 2018;78(7):1713\u201325.","journal-title":"Cancer Res"},{"issue":"3","key":"1883_CR19","first-page":"1361","volume":"38","author":"K Kato","year":"2018","unstructured":"Kato K, Shimasaki M, Kato T, Segami N, Ueda Y. Expression of sphingosine Kinase-1 is associated with invasiveness and poor prognosis of Oral squamous cell carcinoma. Anticancer Res. 2018;38(3):1361\u20138.","journal-title":"Anticancer Res"},{"issue":"5","key":"1883_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/bjc.2012.14","volume":"106","author":"J Nunes","year":"2012","unstructured":"Nunes J, Naymark M, Sauer L, Muhammad A, Keun H, Sturge J, et al. Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection. Br J Cancer. 2012;106(5):909\u201315.","journal-title":"Br J Cancer"},{"issue":"4","key":"1883_CR21","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1158\/1078-0432.CCR-08-1158","volume":"15","author":"W Li","year":"2009","unstructured":"Li W, Yu CP, Xia JT, Zhang L, Weng GX, Zheng HQ, et al. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res. 2009;15(4):1393\u20139.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"1883_CR22","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1158\/1078-0432.CCR-08-0754","volume":"14","author":"J Li","year":"2008","unstructured":"Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, et al. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res. 2008;14(21):6996\u20137003.","journal-title":"Clin Cancer Res"},{"key":"1883_CR23","doi-asserted-by":"crossref","unstructured":"Yamada A, Nagahashi M, Aoyagi T, Huang WC, Lima S, Hait NC, et al. ABCC1-exported Sphingosine-1-phosphate, produced by sphingosine kinase 1 shortens survival of mice and patients with breast Cancer. Mol Cancer Res. 2018; pii: molcanres.0353.2017.","DOI":"10.1158\/1538-7445.SABCS17-P5-03-05"},{"issue":"1","key":"1883_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-007-9836-9","volume":"112","author":"E Ruckh\u00e4berle","year":"2008","unstructured":"Ruckh\u00e4berle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat. 2008;112(1):41\u201352.","journal-title":"Breast Cancer Res Treat"},{"key":"1883_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/excr.2002.5658","volume":"281","author":"VE Nava","year":"2002","unstructured":"Nava VE, Hobson JP, Murthy S, Milstien S, Spiegel S. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res. 2002;281:115\u201327.","journal-title":"Exp Cell Res"},{"key":"1883_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.breast.2016.02.016","volume":"27","author":"M Soares","year":"2016","unstructured":"Soares M, Madeira S, Correia J, Peleteiro M, Cardoso F, Ferreira F. Molecular based subtyping of feline mammary carcinomas and clinicopathological characterization. Breast. 2016;27:44\u201351.","journal-title":"Breast."},{"issue":"1","key":"1883_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jss.2016.06.022","volume":"205","author":"J Tsuchida","year":"2016","unstructured":"Tsuchida J, Nagahashi M, Nakajima M, Moro K, Tatsuda K, Ramanathan R, et al. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis. J Surg Res. 2016;205(1):85\u201394.","journal-title":"J Surg Res"},{"issue":"12","key":"1883_CR28","first-page":"5684","volume":"9","author":"SI Do","year":"2017","unstructured":"Do SI, Kim HS, Kim K, Lee H, Do IG, Kim DH, et al. Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast. Am J Transl Res. 2017;9(12):5684\u201395.","journal-title":"Am J Transl Res"},{"key":"1883_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.steroids.2015.10.009","volume":"104","author":"O Sukocheva","year":"2015","unstructured":"Sukocheva O, Wadham C, Gamble J, Xia P. Sphingosine-1-phosphate receptor 1 transmits estrogens effects in endothelial cells. Steroids. 2015;104:237\u201345.","journal-title":"Steroids."},{"issue":"5","key":"1883_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s13058-014-0426-6","volume":"16","author":"H Alshaker","year":"2014","unstructured":"Alshaker H, Krell J, Frampton AE, Waxman J, Blyuss O, Zaikin A, et al. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Res. 2014;16(5):426.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"1883_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathologic prognostic factors in breast cancer, I: the value of histologic grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403\u201310.","journal-title":"Histopathology."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-1883-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-1883-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-1883-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T05:58:29Z","timestamp":1663480709000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-1883-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1883"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-1883-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"18 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal procedures used in this study were approved by the Institutional Animal Care and Use Committee (IACUC) of National Chung Hsing University [IACUC Number: 106\u201373<sup>R3<\/sup>].This TMA study was not submitted for ethics committee review because it is a retrospective analysis of FMT tissue blocks. The use of residual FMT tissue samples with informed owner consent was approved by an institutional animal care and use committee (IACUC) under protocol No. 106-073<sup>R3<\/sup>.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"155"}}